nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—CYP1A2—urine—celiac disease	0.135	0.138	CbGeAlD
Duloxetine—NPY1R—pancreas—celiac disease	0.121	0.124	CbGeAlD
Duloxetine—HTR2A—urine—celiac disease	0.105	0.108	CbGeAlD
Duloxetine—NPY1R—blood—celiac disease	0.0987	0.101	CbGeAlD
Duloxetine—CYP2D6—urine—celiac disease	0.0959	0.0982	CbGeAlD
Duloxetine—NPY1R—liver—celiac disease	0.0772	0.079	CbGeAlD
Duloxetine—SLC6A4—digestive system—celiac disease	0.0399	0.0409	CbGeAlD
Duloxetine—SLC6A4—blood—celiac disease	0.038	0.039	CbGeAlD
Duloxetine—HTR2A—connective tissue—celiac disease	0.0293	0.03	CbGeAlD
Duloxetine—HTR2A—epithelium—celiac disease	0.0278	0.0284	CbGeAlD
Duloxetine—CYP1A2—digestive system—celiac disease	0.027	0.0277	CbGeAlD
Duloxetine—HTR2A—smooth muscle tissue—celiac disease	0.0268	0.0274	CbGeAlD
Duloxetine—CYP1A2—blood—celiac disease	0.0257	0.0264	CbGeAlD
Duloxetine—HTR2A—digestive system—celiac disease	0.0211	0.0216	CbGeAlD
Duloxetine—CYP1A2—liver—celiac disease	0.0201	0.0206	CbGeAlD
Duloxetine—HTR2A—blood—celiac disease	0.0201	0.0206	CbGeAlD
Duloxetine—CYP2D6—digestive system—celiac disease	0.0192	0.0197	CbGeAlD
Duloxetine—CYP2D6—blood—celiac disease	0.0183	0.0188	CbGeAlD
Duloxetine—HTR2A—liver—celiac disease	0.0157	0.0161	CbGeAlD
Duloxetine—CYP2D6—liver—celiac disease	0.0143	0.0147	CbGeAlD
Duloxetine—SLC6A3—Alpha-synuclein signaling—TOR1A—celiac disease	0.00338	0.143	CbGpPWpGaD
Duloxetine—NPY1R—Peptide GPCRs—CCR4—celiac disease	0.0017	0.0718	CbGpPWpGaD
Duloxetine—NPY1R—Peptide GPCRs—CCR3—celiac disease	0.00145	0.0611	CbGpPWpGaD
Duloxetine—NPY1R—G alpha (i) signalling events—RGS1—celiac disease	0.000874	0.0369	CbGpPWpGaD
Duloxetine—NPY1R—Peptide ligand-binding receptors—CCR4—celiac disease	0.000801	0.0338	CbGpPWpGaD
Duloxetine—NPY1R—Peptide ligand-binding receptors—CCR3—celiac disease	0.000681	0.0287	CbGpPWpGaD
Duloxetine—NPY1R—G alpha (i) signalling events—CCR4—celiac disease	0.000676	0.0285	CbGpPWpGaD
Duloxetine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000627	0.0264	CbGpPWpGaD
Duloxetine—NPY1R—G alpha (i) signalling events—CCR3—celiac disease	0.000575	0.0242	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000537	0.0227	CbGpPWpGaD
Duloxetine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000533	0.0225	CbGpPWpGaD
Duloxetine—SLC6A2—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.000528	0.0222	CbGpPWpGaD
Duloxetine—SLC6A3—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.000467	0.0197	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000457	0.0193	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—ARHGAP31—celiac disease	0.000411	0.0173	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—CCR4—celiac disease	0.000409	0.0173	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.000383	0.0162	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—CCR3—celiac disease	0.000348	0.0147	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.000331	0.014	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—RGS1—celiac disease	0.000299	0.0126	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—RGS1—celiac disease	0.000272	0.0115	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000268	0.0113	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—MYO9B—celiac disease	0.000249	0.0105	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000238	0.01	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000231	0.00976	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CCR4—celiac disease	0.000231	0.00975	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.000231	0.00973	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TAGAP—celiac disease	0.000216	0.00911	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CCR4—celiac disease	0.00021	0.00885	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000198	0.00836	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000197	0.00829	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CCR3—celiac disease	0.000197	0.00829	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL10—celiac disease	0.000189	0.00798	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CCR3—celiac disease	0.000179	0.00753	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.00017	0.00718	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000169	0.00711	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—RGS1—celiac disease	0.000161	0.00677	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ARHGAP31—celiac disease	0.000152	0.0064	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CCR4—celiac disease	0.000151	0.00636	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000148	0.00624	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000146	0.00615	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000145	0.00611	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CCR3—celiac disease	0.000128	0.00541	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000127	0.00534	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000126	0.0053	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000124	0.00523	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCR4—celiac disease	0.000124	0.00523	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL10—celiac disease	0.000114	0.00481	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ARHGAP31—celiac disease	0.000112	0.00471	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCR4—celiac disease	0.000111	0.00469	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—RGS1—celiac disease	0.00011	0.00465	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000108	0.00454	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCR3—celiac disease	0.000105	0.00445	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—SH2B3—celiac disease	0.000103	0.00433	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—RGS1—celiac disease	0.0001	0.00423	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ARHGAP31—celiac disease	9.7e-05	0.00409	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCR4—celiac disease	9.65e-05	0.00407	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCR3—celiac disease	9.45e-05	0.00399	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MYO9B—celiac disease	9.19e-05	0.00387	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CCR4—celiac disease	8.53e-05	0.0036	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCR3—celiac disease	8.21e-05	0.00346	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—RGS1—celiac disease	8.13e-05	0.00343	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TAGAP—celiac disease	7.97e-05	0.00336	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCR4—celiac disease	7.75e-05	0.00327	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—RGS1—celiac disease	7.38e-05	0.00311	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CCR3—celiac disease	7.25e-05	0.00306	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—RGS1—celiac disease	7.06e-05	0.00298	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MYO9B—celiac disease	6.77e-05	0.00285	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCR3—celiac disease	6.59e-05	0.00278	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—RGS1—celiac disease	6.41e-05	0.0027	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCR4—celiac disease	6.28e-05	0.00265	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—RGS1—celiac disease	5.92e-05	0.0025	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MYO9B—celiac disease	5.88e-05	0.00248	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TAGAP—celiac disease	5.87e-05	0.00247	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCR4—celiac disease	5.7e-05	0.00241	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCR4—celiac disease	5.45e-05	0.0023	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCR3—celiac disease	5.34e-05	0.00225	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—LCT—celiac disease	5.21e-05	0.0022	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TAGAP—celiac disease	5.09e-05	0.00215	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCR4—celiac disease	4.95e-05	0.00209	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCR3—celiac disease	4.85e-05	0.00205	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CD80—celiac disease	4.75e-05	0.002	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCR3—celiac disease	4.64e-05	0.00196	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCR4—celiac disease	4.58e-05	0.00193	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—LCT—celiac disease	4.41e-05	0.00186	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—RGS1—celiac disease	4.36e-05	0.00184	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCR3—celiac disease	4.21e-05	0.00178	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCR3—celiac disease	3.89e-05	0.00164	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SH2B3—celiac disease	3.79e-05	0.0016	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RGS1—celiac disease	3.79e-05	0.0016	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR4—celiac disease	3.37e-05	0.00142	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR4—celiac disease	2.93e-05	0.00123	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR3—celiac disease	2.86e-05	0.00121	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SH2B3—celiac disease	2.79e-05	0.00118	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR3—celiac disease	2.49e-05	0.00105	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SH2B3—celiac disease	2.42e-05	0.00102	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CD80—celiac disease	1.75e-05	0.000739	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CD80—celiac disease	1.29e-05	0.000545	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CD80—celiac disease	1.12e-05	0.000473	CbGpPWpGaD
